560
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Antiviral activity of Vigna radiata extract against feline coronavirus in vitro

, ORCID Icon, , , , , , & ORCID Icon show all
Pages 1-13 | Received 16 Oct 2023, Accepted 25 Apr 2024, Published online: 07 May 2024

References

  • Addie DD, Curran S, Bellini F, Crowe B, Sheehan E, Ukrainchuk L, Decaro N. 2020. Oral Mutian(R)X stopped faecal feline coronavirus shedding by naturally infected cats. Res Vet Sci. 130:222–229. doi: 10.1016/j.rvsc.2020.02.012.
  • Addie DD, Schaap IAT, Nicolson L, Jarrett O. 2003. Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol. 84(Pt 10):2735–2744. doi: 10.1099/vir.0.19129-0.
  • Al-Homidan IH, Ebeid TA, Al-Muzaini A, Abou-Emera OK, Mostafa MM, Fathi MM. 2020. Impact of dietary fenugreek, mung bean, and garden cress on growth performance, carcass traits, blood measurements, and immune response in broiler chickens. Livest Sci. 242:104318. doi: 10.1016/j.livsci.2020.104318.
  • Amer A, Suri AS, Rahman OA, Mohd HB, Faruku B, Saeed S, Azmi TIT. 2012. Isolation and molecular characterization of type I and type II feline coronavirus in Malaysia. Virol J. 9(1):278. doi: 10.1186/1743-422X-9-278.
  • Amoroso MG, Serra F, Miletti G, Cardillo L, de Martinis C, Marati L, Alfano F, Ferrara G, Pagnini U, De Carlo E, et al. 2022. A retrospective study of viral molecular prevalences in cats in southern Italy (Campania Region). Viruses-Basel. 14(11):2583. doi: 10.3390/v14112583.
  • Berenbaum MC. 1989. What is synergy? Pharmacol Rev. 41(2):93–141.
  • Cáceres CJ, Cardenas-Garcia S, Carnaccini S, Seibert B, Rajao DS, Wang J, Perez DR. 2021. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. Sci Rep. 11(1):9609. doi: 10.1038/s41598-021-89013-w.
  • Chandel NS. 2021. Nucleotide Metabolism. Cold Spring Harb Perspect Biol. 13(9):a040592. doi: 10.1101/cshperspect.a040576.
  • Coggins SJ, Norris JM, Malik R, Govendir M, Hall EJ, Kimble B, Thompson MF. 2023. Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524. J Vet Intern Med. 37(5):1772–1783. doi: 10.1111/jvim.16803.
  • Delaplace M, Huet H, Gambino A, Le Poder S. 2021. Feline coronavirus antivirals: a review. Pathogens. 10(9):1150. doi: 10.3390/pathogens10091150.
  • Dye C, Siddell SG. 2007. Genomic RNA sequence of feline coronavirus strain FCoV C1Je. J Feline Med Surg. 9(3):202–213. doi: 10.1016/j.jfms.2006.12.002.
  • Green J, Syme H, Tayler S. 2023. Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. J Vet Intern Med. 37(5):1784–1793. doi: 10.1111/jvim.16804.
  • Hohdatsu T, Nakamura M, Ishizuka Y, Yamada H, Koyama H. 1991. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol. 120(3–4):207–217. doi: 10.1007/BF01310476.
  • Hohdatsu T, Yamada M, Tominaga R, Makino K, Kida K, Koyama H. 1998. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus. J Vet Med Sci. 60(1):49–55. doi: 10.1292/jvms.60.49.
  • Hou DZ, Yousaf L, Xue Y, Hu JR, Wu JH, Hu XS, Feng NH, Shen Q. 2019. Mung bean (Vigna radiata L.): bioactive polyphenols, polysaccharides, peptides, and health benefits. Nutrients. 11(6):1238. doi: 10.3390/nu11061238.
  • Hu CJ, Chang WS, Fang ZS, Chen YT, Wang WL, Tsai HH, Chueh LL, Takano T, Hohdatsu T, Chen HW. 2017. Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus. Sci Rep. 7(1):13043. doi: 10.1038/s41598-017-13316-0.
  • Ianevski A, Giri AK, Aittokallio T. 2022. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. 50(W1):W739–W743. doi: 10.1093/nar/gkac382.
  • Ianevski A, Giri AK, Gautam P, Kononov A, Potdar S, Saarela J, Wennerberg K, Aittokallio T. 2019. Prediction of drug combination effects with a minimal set of experiments. Nat Mach Intell. 1(12):568–577. doi: 10.1038/s42256-019-0122-4.
  • Jaimes JA, Whittaker GR. 2018. Feline coronavirus: insights into viral pathogenesis based on the spike protein structure and function. Virology. 517:108–121. doi: 10.1016/j.virol.2017.12.027.
  • Jones S, Novicoff W, Nadeau J, Evans S. 2021. Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals. 11(8). doi: 10.3390/ani11082257.
  • Ke YY, Peng TT, Yeh TK, Huang WZ, Chang SE, Wu SH, Hung HC, Hsu TA, Lee SJ, Song JS, et al. 2020. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Biomed J. 43(4):355–362. doi: 10.1016/j.bj.2020.05.001.
  • Kim Y, Liu H, Kankanamalage AC, Weerasekara S, Hua DH, Groutas WC, Chang KO, Pedersen NC. 2016. Correction: reversal of the progression of fatal coronavirus infec­tion in cats by a broad-spectrum coronavirus protease inhibitor. PLOS Pathog. 12(5):e1005650. doi: 10.1371/journal.ppat.1005650.
  • Kim Y, Shivanna V, Narayanan S, Prior AM, Weerasekara S, Hua DH, Kankanamalage AC, Groutas WC, Chang KO. 2015. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses. J Virol. 89(9):4942–4950. doi: 10.1128/JVI.03688-14.
  • Kipar A, Meli ML. 2014. Feline infectious peritonitis still an enigma? Vet Pathol. 51(2):505–526. doi: 10.1177/0300985814522077.
  • Klein-Richers U, Hartmann K, Hofmann-Lehmann R, Unterer S, Bergmann M, Rieger A, Leutenegger C, Pantchev N, Balzer J, Felten S. 2020. Prevalence of feline coronavirus shedding in german catteries and associated risk factors. Viruses. 12(9):1000. doi: 10.3390/v12091000.
  • Kummrow M, Meli ML, Haessig M, Goenczi E, Poland A, Pedersen NC, Hofmann-Lehmann R, Lutz H. 2005. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol. 12(10):1209–1215. doi: 10.1128/CDLI.12.10.1209-1215.2005.
  • Lee DN, Hung YS, Yang TS, Lin JH, Weng CF. 2017. Aspergillus awamori-fermented mung bean seed coats enhance the antioxidant and immune responses of weaned pigs. J Anim Physiol Anim Nutr. 101(5):e342–e351. doi: 10.1111/jpn.12611.
  • Lo CW, Pi CC, Chen YT, Chen HW. 2020. Vigna radiata (L.) R. Wilczek extract inhibits influenza a virus by targeting viral attachment, penetration, assembly, and release. Front Pharmacol. 11:584973. doi: 10.3389/fphar.2020.584973.
  • Murota K, Nakamura Y, Uehara M. 2018. Flavonoid metabolism: the interaction of metabolites and gut microbiota. Biosci Biotechnol Biochem. 82(4):600–610. doi: 10.1080/09168451.2018.1444467.
  • Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC. 2018. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 219:226–233. doi: 10.1016/j.vetmic.2018.04.026.
  • Pang X, Xu W, Liu Y, Li H, Chen L. 2023. The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022. Eur J Med Chem. 257:115491. doi: 10.1016/j.ejmech.2023.115491.
  • Pedersen NC, Kim Y, Liu HW, Kankanamalage ACG, Eckstrand C, Groutas WC, Bannasch M, Meadows JM, Chang KO. 2018. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med Surg. 20(4):378–392. doi: 10.1177/1098612X17729626.
  • Pedersen NC, Perron M, Bannasch M, Montgomery E, Murakami E, Liepnieks M, Liu H. 2019. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg. 21(4):271–281. doi: 10.1177/1098612X19825701.
  • Perera KD, Rathnayake AD, Liu H, Pedersen NC, Groutas WC, Chang KO, Kim Y. 2019. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor. Vet Microbiol. 237:108398. doi: 10.1016/j.vetmic.2019.108398.
  • Rottier PJM, Nakamura K, Schellen P, Volders H, Haijema BJ. 2005. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol. 79(22):14122–14130. doi: 10.1128/JVI.79.22.14122-14130.2005.
  • Takano T, Hohdatsu T, Toda A, Tanabe M, Koyama H. 2007. TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology. 364(1):64–72. doi: 10.1016/j.virol.2007.02.006.
  • Takano T, Kawakami C, Yamada S, Satoh R, Hohdatsu T. 2008. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. J Vet Med Sci. 70(12):1315–1321. doi: 10.1292/jvms.70.1315.
  • Tan B, Joyce R, Tan H, Hu Y, Wang J. 2023. SARS-CoV-2 main protease drug design, assay development, and drug resistance studies. Acc Chem Res. 56(2):157–168. doi: 10.1021/acs.accounts.2c00735.
  • Triratapiban C, Lueangaramkul V, Phecharat N, Pantanam A, Lekcharoensuk P, Theerawatanasirikul S. 2023. First study on in vitro antiviral and virucidal effects of flavonoids against feline infectious peritonitis virus at the early stage of infection. Vet World. 16(3):618–630. doi: 10.14202/vetworld.2023.618-630.
  • Vitiello A. 2022. Sars-Cov-2 and risk of antiviral drug resistance. Ir J Med Sci. 191(5):2367–2368. doi: 10.1007/s11845-021-02820-y.
  • Yang CW, Peng TT, Hsu HY, Lee YZ, Wu SH, Lin WH, Ke YY, Hsu TA, Yeh TK, Huang WZ, et al. 2020a. Repurposing old drugs as antiviral agents for coronaviruses. Biomed J. 43(4):368–374. doi: 10.1016/j.bj.2020.05.003.
  • Yang TJ, Chang YC, Ko TP, Draczkowski P, Chien YC, Chang YC, Wu KP, Khoo KH, Chang HW, Hsu SD. 2020b. Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans. Proc Natl Acad Sci USA. 117(3):1438–1446. doi: 10.1073/pnas.1908898117.
  • Yen SJ, Chen HW. 2021. Feline coronaviruses identified in feline effusions in suspected cases of feline infectious peritonitis. Microorganisms. 9(9):1801. doi: 10.3390/microorganisms9091801.
  • Zhou Q, Li Y, Huang J, Fu NS, Song X, Sha X, Zhang B. 2021. Prevalence and molecular characteristics of feline coronavirus in southwest China from 2017 to 2020. J Gen Virol. 102.
  • Zwicklbauer K, Krentz D, Bergmann M, Felten S, Dorsch R, Fischer A, Hofmann-Lehmann R, Meli ML, Spiri AM, Alberer M, et al. 2023. Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524. J Feline Med Surg. 25(8):1098612X231183250. doi: 10.1177/1098612X231183250.